ePrivacy and GPDR Cookie Consent by TermsFeed Generator

How does the amended Act on Pharmaceuticals affect the handling of applications for marketing authorisation, applications for marketing authorisation renewal or variation and applications for permission of parallel import that involve the SPC, PIL and l

Information on the handling of applications for marketing authorisation of medicinal products through the national procedure, MRP or DCP, marketing authorisation renewal and applications for marketing authorisation variation through the national procedure, MRP or DCP, and applications for permission of parallel import of a medicinal product, pursuant to Section 32, paragraph 1 of the Act on Pharmaceuticals, is available at http://www.sukl.cz/leciva/zmena-ve-vyrizovani-zadosti-o-registraci-prodlouzeni .